Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Swarraton Partners

Founders Christophe Jungels-Winkler Stephen Brooke

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 7
Average round size
info
The average size of a deal this fund participated in
$5M
Portfolio companies 5
Lead investments 3
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.29
Exits 1
Key employees Soon
Stages of investment
Early Stage Venture
Late Stage Venture

Areas of investment

  • Health Care
  • Electronics
  • Medical Device
  • Diagnostic Equipment
  • Biotechnology
Summary

The venture was found in Europe in United Kingdom. The leading representative office of defined VC is situated in the London.

The current fund was established by Christophe Jungels-Winkler, Stephen Brooke.

The typical case for the fund is to invest in rounds with 3-4 participants. Despite the Swarraton Partners, startups are often financed by Unilever Ventures, Nesta Ventures, YFM Equity Partners. The meaningful sponsors for the fund in investment in the same round are NAXOS Capital Partners, Unilever Ventures, YFM Equity Partners. In the next rounds fund is usually obtained by Renaissance Capital Partners, Technology Venture Partners, Parkwalk Advisors.

The fund is constantly included in less than 2 investment rounds annually. Deals in the range of 5 - 10 millions dollars are the general things for fund. Comparing to the other companies, this Swarraton Partners performs on 15 percentage points less the average number of lead investments. Speaking about the real fund results, this VC is 9 percentage points more often commits exit comparing to other organizations. The important activity for fund was in 2009.

Among the most popular fund investment industries, there are Health Diagnostics, Energy. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight P2i, Micrima. The fund has no exact preference in some founders of portfolio startups. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United Kingdom.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Swarraton Partners:
Typical Co-investors
Swarraton Partners is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Swarraton Partners:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from United Kingdom
Funds with similar focus located in United Kingdom:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Angel Dough Ventures Hicksville, New York, United States
Atento Capital Oklahoma, Tulsa, United States
Broadway Video Ventures New York, New York, United States
Bryan Garnier & Co France, Ile-de-France, Paris
China Orient Asset Management (International) Holding China, Hong Kong, Hong Kong Island
Chloe Capital Ithaca, New York, United States
Convergys Cincinnati, Ohio, United States
DHM Arcadia Partners Boston, Massachusetts, United States
EnCap Investments Houston, Texas, United States
F3 Ventures New York, New York, United States
Giant Network China, Shanghai
ICE71 Central, Central Region, Singapore
NFX Ventures -
Northview LifeSciences British Columbia, Canada, Vancouver
Pays de la Loire Participations France, Nantes, Pays de la Loire
Propeller Inc. Amman, Amman, Jordan
Reach Ventures Chagrin Falls, Ohio, United States
RK Mellon -
Sage Technology Ventures California, Fremont, United States
Spotify Stockholm, Stockholm County, Sweden

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Energy
Industrial
Renewable Energy
$5M07 Jun 2010 East Suffolk, England, United Kingdom

i2O

Electronics
Water
$5M01 Nov 2009 Southampton, England, United Kingdom

P2i

Apps
Electronics
Nanotechnology
$5M20 Jul 2009 United Kingdom, England

TheraGenetics

Genetics
Health Care
Health Diagnostics
Medical
$6M10 Jul 2007 London, England, United Kingdom

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Swarraton Partners?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 7
Average round size 5M
Peak activity year 2009
Lead investments 3
Follow on index 0.29
Exits 1
Group Appearance index 0.86

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Energy
Industrial
Renewable Energy
$5M07 Jun 2010 East Suffolk, England, United Kingdom

i2O

Electronics
Water
$5M01 Nov 2009 Southampton, England, United Kingdom

P2i

Apps
Electronics
Nanotechnology
$5M20 Jul 2009 United Kingdom, England

TheraGenetics

Genetics
Health Care
Health Diagnostics
Medical
$6M10 Jul 2007 London, England, United Kingdom
Crunchbase icon

Content report

The following text will be sent to our editors: